The National Kidney Foundation (NKF) has awarded Jayme Locke, MD, MPH, FACS, FAST, Vice President, Medical Development, ...

Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide ...

Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ...

Healthcare pioneer Laura Shawver, Ph.D. appointed Chair of the Board and industry veteran Roy Baynes M.D., Ph.D. appointed as independent, non-exe ...

Study finds AI chatbot significantly improve symptoms for those suffering from major depressive disorder (MDD), generalized ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

M.D., Ph.D., President and Chief Executive Officer of Black Diamond Therapeutics. "Servier's commitment to innovation and deep expertise in oncology make it an ideal partner for Black Diamond as we ...

M.D., Ph.D., President and Chief Executive Officer of Black Diamond Therapeutics. “Servier’s commitment to innovation and deep expertise in oncology make it an ideal partner for Black Diamond ...

M.D., Ph.D., President and Chief Executive Officer of Black Diamond Therapeutics. "Servier's commitment to innovation and deep expertise in oncology make it an ideal partner for Black Diamond as we ...

Earlier this month, Ian Lipkin, M.D., and his team at Columbia University submitted a paper for publication that suggests ...

Life Sciences announced today that it is building on OFD's 60 plus years of lyophilization expertise with multiple leadership appointments to its recently created Life Sciences division and the ...